{
    "root": "3622a08a-dc02-ac27-e063-6394a90ac8bb",
    "code": "34391-3",
    "codeSystem": "2.16.840.1.113883.6.1",
    "displayName": "HUMAN PRESCRIPTION DRUG LABEL",
    "name": "Benztropine Mesylate",
    "value": "20250527",
    "ingredients": [
        {
            "name": "CALCIUM PHOSPHATE, DIBASIC, DIHYDRATE",
            "code": "O7TSZ97GEP",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_77635"
        },
        {
            "name": "CROSCARMELLOSE SODIUM",
            "code": "M28OL1HH48"
        },
        {
            "name": "LACTOSE MONOHYDRATE",
            "code": "EWQ57Q8I5X",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_17716"
        },
        {
            "name": "MAGNESIUM STEARATE",
            "code": "70097M6I30",
            "drugbank_id": "https://go.drugbank.com/drugs/DB14077"
        },
        {
            "name": "CELLULOSE, MICROCRYSTALLINE",
            "code": "OP1R32D61U"
        },
        {
            "name": "BENZTROPINE MESYLATE",
            "code": "WMJ8TL7510",
            "drugbank_id": "https://go.drugbank.com/drugs/DB00245"
        }
    ],
    "indications": {
        "text": "adjunct therapy forms parkinsonism . useful also control extrapyramidal disorders ( except tardive dyskinesia \u2013 ) due neuroleptic drugs ( e.g . , phenothiazines ) .",
        "doid_entities": [
            {
                "text": "parkinsonism (DOID:0080855)",
                "doid_id": "http://purl.obolibrary.org/obo/DOID_0080855"
            },
            {
                "text": "dyskinesia (DOID:306)",
                "doid_id": "http://purl.obolibrary.org/obo/DOID_306"
            }
        ],
        "orphanet_entities": []
    },
    "contraindications": {
        "text": "benztropine mesylate tablets used patients able take oral medication . cumulative action , therapy initiated low dose increased gradually five- six-day intervals smallest amount necessary optimal relief . increases made increments 0.5 mg , maximum 6 mg , optimal results obtained without excessive .",
        "doid_entities": [],
        "orphanet_entities": []
    },
    "warningsAndPrecautions": "benztropine mesylate tablets , usp available follows : 1 mg : white , oval , scored tablets , debossed `` 2326 `` one side debossed `` v `` reverse side , supplied ndc : 70518-0132-00 ndc : 70518-0132-01 packaging : 30 1 blister pack packaging : 30 1 blister pack dispense well-closed container defined usp . store 20\u00b0 25\u00b0c ( 68\u00b0 77\u00b0f ) [ usp controlled room temperature ] . repackaged distributed : remedy repack , inc. 625 kolter dr. suite # 4 indiana , pa 1-724-465-8762",
    "adverseReactions": "hypersensitivity benztropine mesylate tablets . atropine-like side effects , contraindicated pediatric patients three years age , used caution older pediatric patients .",
    "indications_original": "For use as an adjunct in the therapy of all forms of parkinsonism.\n                  Useful also in the control of extrapyramidal disorders (except tardive dyskinesia \u2013 see \n       \n \n  \n                        PRECAUTIONS\n                     ) due to neuroleptic drugs (e.g., phenothiazines).",
    "contraindications_original": "Benztropine mesylate tablets should be used when patients are able to take oral medication.\n                  Because of cumulative action, therapy should be initiated with a low dose which is increased gradually at five- or six-day intervals to the smallest amount necessary for optimal relief. Increases should be made in increments of 0.5 mg, to a maximum of 6 mg, or until optimal results are obtained without excessive adverse reactions.",
    "warningsAndPrecautions_original": "Benztropine Mesylate Tablets, USP are available as follows:\n                  1 mg: white, oval, scored tablets, debossed \"2326\" on one side and debossed \"V\" on the reverse side, supplied in\n                  NDC: 70518-0132-00\n                  NDC: 70518-0132-01\n                  PACKAGING: 30 in 1 BLISTER PACK\n                  PACKAGING: 30 in 1 BLISTER PACK\n                  \n                  Dispense in a well-closed container as defined in the USP.\n                  Store at 20\u00b0 to 25\u00b0C (68\u00b0 to 77\u00b0F) [see USP Controlled Room Temperature].\n                  \n                  Repackaged and Distributed By:\n                  Remedy Repack, Inc.\n                  625 Kolter Dr. Suite #4 Indiana, PA 1-724-465-8762",
    "adverseReactions_original": "Hypersensitivity to benztropine mesylate tablets.\n                  Because of its atropine-like side effects, this drug is contraindicated in pediatric patients under three years of age, and should be used with caution in older pediatric patients.",
    "drug": [
        {
            "name": "Benztropine Mesylate",
            "drugbank_id": "https://go.drugbank.com/drugs/DB00245"
        }
    ]
}